Skip to main content
. 2025 Jul 20;17(7):936. doi: 10.3390/pharmaceutics17070936
TDD Transdermal drug delivery
NSAI Non-steroidal aromatase inhibitor
APIs Active pharmaceutical ingredients
OLZ Olanzapine
PEK Perilla-ketone
DOTAR 1,2-dioleoyloxy-3-trimethylammoniumpropan
ATRA All-trans retinoic acid
PA Phosphatidic acid
PEA Phosphatidylethanol
PC Phosphatidylcholine
PG Phosphatidylglycerol
PEG Polyethylene glycol
PI Phosphatidylinositol
PS Phosphatidylserine
PDI Polydispersity index
PLGA Poly (lactic-co-glycolic) acid
mPEG Methoxypolyethylene glycol
PBA-G5D Phenylboronic acid-PAMAM dendrimer
PTX Paclitaxel
PEC Polyelectrolyte complex
SLNs Solid Lipid Nanoparticles
NLCs Nanostructured Lipid Carriers
PELNVs Plant exosome-like vesicles
ROS Reactive oxygen species
VDCs Vertical Diffusion Cells
MIVO® Multi In Vitro Organ
PAMPA Parallel Artificial Membrane Permeability Assay
PSU Polysulfone
PES Polyethersulfone
RHE Reconstructed human epidermis
FT Full-thickness
HPLC High-Performance Liquid Chromatography
CLSM Confocal Laser Scanning Microscopy
CRS Confocal Raman Spectroscopy
DOFM Dermal Open-Flow Microperfusion
Cmax Maximum plasma concentration
AUC Area Under the Curve
AUC0−t Area Under the Curve from time zero to the last measurable concentration
AUC0−∞ Area Under the Curve from time zero extrapolated to infinity—gives the complete systemic exposure
FDA The United States Food and Drug Administration
EAEU The Eurasian Economic Union
EEU The Eurasian Economic Union
EMA The European Medicines Agency
IVRT In vitro release test
IVPT In vitro permeation test